Medtech Investment Working Group – Quarterly Meeting

Join us for a breakdown of the Chinese medical device market, to review the current regulatory requirements and pathways, and address I.P. protection in China for U.S. companies.

Scott Whitaker, president and CEO of AdvaMed, recently chatted with Joe Mullings, chairman and CEO of The Mullings Group, about the impact of the medtech industry and the importance of connections.

Following the introduction of the bipartisan American Innovation and Jobs Act in the U.S. Senate and its House companion the American Innovation and R&D Competitiveness Act, AdvaMed, the MedTech Association, called on lawmakers to quickly pass the legislation which would allow for small companies to deduct their research and development expenses in the year they are incurred. Currently, companies are required to deduct their expenses over the course of five years.

AdvaMed’s medtech priorities for the 118th Congress highlight opportunities to address the most important issues facing patients and the medical technology industry today.

From MDUFA V and the major investments in semiconductor chip manufacturing in the CHIPS Act, to addressing global supply chain issues and supporting our AdvaMed Accel companies, 2022 was a year like no other.

This report from PwC presents three growth strategies to empower medtech companies to win in this competitive and rapidly changing environment.

The Advanced Medical Technology Association (AdvaMed) this week concluded its annual The Medtech Conference, a content-packed three days in a return to fully in-person events. The Medtech Conference, regarded as the largest gathering for the global medtech community, broke attendance and international representation records in promoting the ideas, partnerships, and innovations that serve patients worldwide.